Tue, 20 Jan 2009 17:13:31 -0500 MBL Communications http://psychcast.mblcommunications.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker PsychCast™ is designed to enable physicians to simply and easily listen to a compilation of insightful, 20-35 minute interviews with internationally recognized researchers and clinicians in the fields of psychiatry and neuropsychiatry. Expert interviews are gathered from Primary Psychiatry, The Largest Peer Reviewed Psychiatric Journal in the Nation, and CNS Spectrums, The International Journal of Neuropsychiatric Medicine. Additional PsychCast™ programming includes peer-reviewed expert panel dialogues, case-based psychopharmacology lessons, and CME-accredited educational programs designed to provide our 115,000+ monthly readers with an additional level of personalization in the era of multi-channel learning en 2007 MBL Communications MBL Communications info@mblcommunications.com http://psychcast.mblcommunications.com/audio/PsychcastEI_144.jpg http://psychcast.mblcommunications.com 144 116 Medicine cme,interviews,psychology,psychiatry no MBL Communications Narcolepsy Dr. Siegel is professor of psychiatry at the University of California, Los Angeles, former president of the Sleep Research Society, and the recipient of Merit and Javits awards from the National Institutes of Health and the Distinguished Scientist award from the Sleep Research Society. His laboratory has made discoveries concerning the role of hypocretin in human narcolepsy and Parkinson’s disease. He has studied the phylogeny of sleep as a clue to sleep function, discovering that the primitive mammal platypus has rapid eye movement sleep and that marine mammals can go without extended periods of sleep for long periods without ill effects. http://psychcast.mblcommunications.com/audio/26siegel.m4a Tue, 20 Jan 2009 17:12:37 -0500 Medicine no 00:28:44 cme,interviews,psychology,psychiatry MBL Communications Schizophrenia Dr. Perkins is professor of psychiatry in the Department of Psychiatry at the University of North Carolina (UNC) School of Medicine in Chapel Hill. She is medical director of Outreach and Support Intervention Services at UNC Hospitals and the UNC-Chapel Hill School of Medicine. Dr. Perkins’ research emphasizes treatment of the prodromal period and early intervention of the first episode of schizophrenia. Currently investigating pharmacologic and psychotherapeutic treatments for psychosis, she focuses on managing side effects of atypical antipsychotics and the weight gain mechanism in patients taking psychotropic medications. In addition, Dr. Perkins is investigating the genetic basis of schizophrenia. http://psychcast.mblcommunications.com/audio/25Perkins.m4a Tue, 16 Dec 2008 16:48:59 -0500 Medicine no 00:38:41 cme,interviews,psychology,psychiatry MBL Communications Fibromyalgia Dr. Turk is John and Emma Bonica Professor of Anesthesiology and Pain Research and director of the Fibromyalgia Research Program at the University of Washington in Seattle, Washington. http://psychcast.mblcommunications.com/audio/24turk.m4a Mon, 01 Dec 2008 16:09:00 -0500 Medicine no 00:23:00 cme,interviews,psychology,psychiatry MBL Communications Alzheimer’s Disease Dr. Gandy is Mount Sinai Professor of Alzheimer’s Disease Research, professor of neurology and psychiatry, associate director of the Mount Sinai Alzheimer’s Disease Research Center in New York City, and past chair of the National Medical and Scientific Advisory Council of the Alzheimer’s Association. As an international expert in the metabolism of amyloid that clogs the brain in patients with Alzheimer’s disease, Dr. Gandy has written over 150 original papers, chapters, and reviews on this topic. In 1989, he and his colleagues discovered medications that could lower the formation of amyloid. He has received continuous National Institutes of Health funding for his research on amyloid metabolism since 1986. http://psychcast.mblcommunications.com/audio/23gandy.m4a Tue, 16 Sep 2008 11:05:24 -0400 Medicine no 00:20:39 cme,interviews,psychology,psychiatry MBL Communications Bariatric Surgery Dr. Hutcher serves on the advisory board of the American Obesity Association. As past president of the American Society for Metabolic and Bariatric Surgery, he is proactive in issues concerning insurance coverage and medical access for severely obese patients. He was chairman of the Department of Surgery at St. Mary’s Hospital and clinical associate professor at the Medical College of Virginia and the McGuire Veterans Administration Hospital in Richmond, Virginia. Dr. Hutcher’s current practice is devoted almost entirely to the surgical treatment of morbid obesity. http://psychcast.mblcommunications.com/audio/22Hutcher.m4a Thu, 14 Aug 2008 21:48:17 -0400 Medicine no 00:26:14 cme,interviews,psychology,psychiatry MBL Communications Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder Dr. Allen is both assistant professor in the Department of Psychiatry at the Mount Sinai School of Medicine in New York City and director of psychological services at the Mount Sinai School of Medicine Center of Excellence in Compulsive and Impulsive Disorders. Her research interests primarily include the treatment of disorders within the obsessive-compulsive spectrum, including obsessive-compulsive disorder and body dysmorphic disorder. In addition, she trains psychiatrists and psychologists on these conditions. Dr. Allen is a widely published author of numerous original research publications and review articles. http://psychcast.mblcommunications.com/audio/21allen.m4a Tue, 08 Jul 2008 16:03:32 -0400 Medicine no 00:25:51 cme,interviews,psychology,psychiatry MBL Communications Ketamine: New Pathways of Medication Dr. Mathew is assistant professor of Psychiatry at the Mount Sinai School of Medicine in New York City. A board-certified psychiatrist, Dr. Mathew is also attending physician in the Mood and Anxiety Disorders Program at the Mount Sinai Medical Center. In 2007, he received the American Foundation for Suicide Prevention Pfizer Travel Award as well as the Lamport Research Award from the Mount Sinai School of Medicine. In addition to therapeutic approaches for treatment-resistant depression and anxiety, Dr. Mathew’s research involves magnetic resonance imaging and spectroscopy applications to anxiety and mood disorders. http://psychcast.mblcommunications.com/audio/20mathew.m4a Mon, 16 Jun 2008 17:18:24 -0400 Medicine no 00:22:49 cme,interviews,psychology,psychiatry MBL Communications The Status of the Primary Care Field in Relation to Psychiatric Care Dr. King is president of the American Academy of Family Physicians (AAFP), which respresents 94,000 physicians and medical students nationwide. He is volunteer faculty at the University of Tennessee Center for Health Sciences, Memphis, and medical director of Chester County Healthcare Services in Selmer. In 1997, Dr. King received the Family Physician of the Year Award from the Tennessee Academy of Family Physicians. As member of the board of directors of FamMedPAC, the AAFP’s political action committee, Dr. King advocates the legislative goals of family medicine to members of Congress. http://psychcast.mblcommunications.com/audio/19king.m4a Wed, 04 Jun 2008 14:28:47 -0400 Medicine no 00:13:41 cme,interviews,psychology,psychiatry MBL Communications Depression, Antidepressants, and Bone Loss Dr. Diem is Assistant Professor of Medicine at the University of Minnesota. She is a general internist, epidemiologist, and clinical trialist of women’s health. In addition, her clinical practice is primarily focused on perimenopausal and postmenopausal women. Dr. Diem is co-investigator on the Study of Osteoporotic Fractures, a prospective cohort study funded by the National Institutes of Health that examines the risk factors for osteoporosis and fractures in postmenopausal women. http://psychcast.mblcommunications.com/audio/18diem.m4a Fri, 25 Apr 2008 16:41:03 -0400 Medicine no 00:13:09 cme,interviews,psychology,psychiatry MBL Communications An Update on the Sexual Side Effects of Medication Dr. Clayton is David C. Wilson professor of psychiatry and professor of clinical obstetrics and gynecology at the University of Virginia in Charlottesville. She is distinguished fellow of the American Psychiatric Association and certified by the American Board of Psychiatry and Neurology. Dr. Clayton is consulting editor for the Journal of Sex & Marital Therapy and received the Columnist of the Year award in 2005 for her bi-monthly column in Primary Psychiatry, “Considerations in Women’s Mental Health.” In 2007, her book, Satisfaction: Women, Sex and the Quest for Intimacy, was published for the general public. http://psychcast.mblcommunications.com/audio/17Clayton.m4a Fri, 14 Mar 2008 02:16:19 -0400 Medicine no 00:19:04 cme,interviews,psychology,psychiatry MBL Communications 250 publications in psychiatric literature, including Principles and Practice of Psychopharmacotherapy.]]> Neuromodulation Dr. Janicak is professor of Psychiatry at Rush University in Chicago, Illinois, medical director of the Rush Psychiatric Clinical Research Center, and distinguished fellow at the American Psychiatric Association. He has been listed in Best Doctors of America since 1996 and Who’s Who in America since 2002. In 2003, the Illinois chapter of the National Alliance for the Mentally Ill named Dr. Janicak “Psychiatrist of the Year.” With a strong interest in the assessment and treatment of mood and psychotic disorders, he has been a National Institute of Mental Health grant awardee as both principal and co-investigator. Dr. Janicak is editor of the Psychopharm Review and has authored >250 publications in psychiatric literature, including Principles and Practice of Psychopharmacotherapy. http://psychcast.mblcommunications.com/audio/16janicak.m4a Fri, 15 Feb 2008 00:02:24 -0500 Medicine no 00:34:39 cme,interviews,psychology,psychiatry MBL Communications The Comprehensive Textbook of Psychiatry, 8th Edition Dr. Sadock is Menas S. Gregory professor of psychiatry and vice chairman at the New York University (NYU) School of Medicine. He is attending psychiatrist at the Bellevue and Tisch Hospitals and is consulting psychiatrist at Lenox Hill Hospital. Dr. Sadock is diplomate of the American Board of Psychiatry and Neurology and Distinguished Life Fellow of the American Psychiatric Association. He is also president and founder of the NYU-Bellevue Psychiatric Society. He was appointed Faculty Scholar at the NYU School of Medicine in 2000. Dr. Sadock is author and editor of over 100 publications and book reviewer for psychiatric journals, including the American Journal of Psychiatry. http://psychcast.mblcommunications.com/audio/15sadock.m4a Wed, 30 Jan 2008 15:16:45 -0500 Medicine no 00:28:15 cme,interviews,psychology,psychiatry MBL Communications Examining the Strengths and Limitations of Generic Formulations of Antidepressants Dr. Thase is professor of psychiatry at the University of Pennsylvania School of Medicine in Philadelphia. He is a distinguished fellow of the American Psychiatric Association and a founding fellow of the Academy of Cognitive Therapy, a non-profit mental health organization dedicated to serving people with mental health disorders. He is director of the American Society of Clinical Psychopharmocology and vice chairman on the Scientific Advisory Board of the National Depression and Bipolar Support Alliance. Dr. Thase’s research centers on the evaluation and treatment of mood disorders. http://psychcast.mblcommunications.com/audio/14Thase.m4a Sun, 06 Jan 2008 02:23:25 -0500 Medicine no 00:22:16 cme,interviews,psychology,psychiatry MBL Communications Bipolar Disorder Dr. Goldberg is director of the Affective Disorders Program at Silver Hill Hospital in New Canaan, Connecticut, and associate clinical professor of psychiatry at the Mount Sinai School of Medicine in New York City. His research focuses on the treatment and clinical features of bipolar disorder. He is a co-investigator in the National Institute of Mental Health (NIMH) Systematic Treatment Enhancement Program for Bipolar Disorder and has received a Career Development Award from the NIMH. He has also received research grants from the National Alliance for Research in Schizophrenia and Depression, the American Foundation for Suicide Prevention, and the Stanley Foundation. http://psychcast.mblcommunications.com/audio/13Goldberg.m4a Wed, 21 Nov 2007 02:04:07 -0500 Medicine no 00:37:06 cme,interviews,psychology,psychiatry MBL Communications Newer Antipsychotics and the Differences Between Clinical Experiences and Clinical Trials Dr. Marder is professor at the Semel Institute of Neuroscience and Human Behavior at the University of California, Los Angeles (UCLA); director of the Veterans Integrated Service Network 22 Mental Illness Research, Education, and Clinical Center at the Department of Veterans Affairs in Los Angeles; and director of the Section on Psychosis at the UCLA Semel Institute. Dr. Marder’s research has focused on the treatment of schizophrenia and the pharmacology of antipsychotics. http://psychcast.mblcommunications.com/audio/12Marder.m4a Mon, 15 Oct 2007 12:26:38 -0400 Medicine no 00:25:13 cme,interviews,psychology,psychiatry MBL Communications Anxiety and Comorbid Measures Associated with Plexin A2 Dr. Wray is a statistical geneticist specializing in the genetics of complex diseases. She is senior research officer at Queensland Institute of Medical Research in Brisbane, Australia, where she leads the Anxiety and Depression Study of the Genetic Epidemiology Laboratory. The study represents a powerful design to identify a large cohort of individuals for genetic analysis for whom comorbidity between depression and anxiety subtypes is fully documented. This interview was conducted by Norman Sussman, MD, on May 2, 2007, and is published in the September 2007 Primary Psychiatry. Disclosure: Dr. Wray receives grant support from the Australian National Health and Medical Research Council, the National Institutes of Health, and Sequenom, Inc. http://psychcast.mblcommunications.com/audio/11Wray.m4a Wed, 19 Sep 2007 19:08:40 -0400 Medicine no 00:28:51 cme,interviews,psychology,psychiatry MBL Communications Tardive Dyskinesia Dr. Lieberman is the Lawrence E. Kolb Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons and director of the New York State Psychiatric Institute in New York City. He also holds the Lieber Chair and directs the Lieber Center for Schizophrenia Research in the Department of Psychiatry at Columbia, and serves as the principal investigator of the Clinical Antipsychotic Trials of Intervention Effectiveness Research Program sponsored by the National Institute of Mental Health. Dr. Lieberman’s research focuses on the neurobiology, pharmacology, and treatment of schizophrenia and related psychotic disorders. http://psychcast.mblcommunications.com/audio/10Leberman.m4a Tue, 28 Aug 2007 20:12:12 -0400 Medicine no 00:25:08 cme,interviews,psychology,psychiatry MBL Communications The Developmental Process for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Dr. Regier is executive director of the American Psychiatric Institute for Research and Education and director of the Division of Research at the American Psychiatric Association. During his 25 years at the National Institute of Mental Health, Dr. Regier was involved with the World Health Organization in international programs on the classification of mental disorders. He currently serves as vice chair of the task force to develop the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This interview was conducted by Norman Sussman, MD, on April 16, 2007, and is published in the July 2007 Primary Psychiatry. Disclosure: Dr. Regier oversees all federal- and industry-sponsored research and research training grants at the American Psychiatric Institute for Research and Education but receives no external salary funding or honoraria from any government or industry sources. http://psychcast.mblcommunications.com/audio/09Reiger.m4a Sat, 14 Jul 2007 13:27:35 -0400 Medicine no 00:27:18 cme,interviews,psychology,psychiatry MBL Communications The Impact and Psychological Manifestations of Thyroid Dysfunction Dr. Joffe is professor of psychiatry at the University of Medicine and Dentistry of New Jersey and staff psychiatrist at The University Hospital, both in Newark. Dr. Joffe has been listed in The Best Doctors in America in 2005–2006. His research interests include depression, bipolar disorder, and psychoneuroendocrinology. This interview was conducted by Norman Sussman, MD, on January 26, 2007, and is published in the June 2007 Primary Psychiatry. Disclosure: Dr. Joffe reports no affiliation with or financial interest in any organization that may pose a conflict of interest. http://psychcast.mblcommunications.com/audio/08Joffe.m4a Thu, 14 Jun 2007 20:47:26 -0400 Medicine no 00:18:41 MBL Communications The Dermatological Side Effects of Pharmacologic Agents Dr. Whitlow is a dermatologist in private practice, and clinical associate professor of dermatology at New York University Medical Center, both in New York City. His clinical interests include allergic and immunologic skin disease. This interview was conducted by Norman Sussman, MD, on January 24, 2007, and is published in the May 2007 Primary Psychiatry. Disclosure: Dr. Whitlow is a consultant to Amgen. http://psychcast.mblcommunications.com/audio/07Whitlow.m4a Tue, 15 May 2007 20:06:41 -0400 Medicine no 00:19:36 MBL Communications The Impact of Suicide on Physicians Dr. Plakun is director of admissions and professional relations, a treatment team leader, psychotherapy supervisor, a member of the management group of the Erik H. Erikson Institute for Education and Research, and co-principal investigator of a prospective study of treatment outcome that utilizes objective measures of psychodynamic constructs at the Austen Riggs Center in Stockbridge, Massachusetts. He is also a distinguished fellow of the American Psychiatric Association and chair of its Committee on Psychotherapy by Psychiatrists. This interview was conducted by Norman Sussman, MD, on December 4, 2006, and is published in the April 2007 Primary Psychiatry. Disclosure: Dr. Plakun reports no affiliation with or financial interest in any organization that may pose a conflict of interest. http://psychcast.mblcommunications.com/audio/06Plakun.m4a Mon, 16 Apr 2007 16:40:02 -0400 Medicine no 00:24:18 MBL Communications Current Developments in Electroconvulsive Therapy Dr. Kellner is professor and chair of the Department of Psychiatry, and assistant dean for clinical research at the University of Medicine and Dentistry of New Jersey in Newark. He is also co-director of the electroconvulsive therapy (ECT) service at The University Hospital in Newark with George Petrides, MD, and was editor of The Journal of ECT from 1994–2004. Dr. Kellner’s ongoing research includes studies comparing different ECT types and methods for optimizing maintenance ECT. This interview was conducted by Norman Sussman, MD, on December 15, 2006, and is published in the March 2007 Primary Psychiatry. Disclosure: Dr. Kellner receives grant support from the National Center for Complementary and Alternative Medicine and the National Institute of Mental Health. http://psychcast.mblcommunications.com/audio/05Kellner.m4a Thu, 15 Mar 2007 23:21:24 -0400 Medicine no 00:26:45 MBL Communications The Sequenced Treatment Alternatives to Relieve Depression Study: Recent Results Dr. Nierenberg is associate director of the Depression Clinical and Research Program at Massachusetts General Hospital and associate professor of psychiatry at Harvard Medical School in Boston. He is also director of the National Institute of Mental Health Bipolar Trials Network, a federally-funded infrastructure for the next generation of clinical trials to help patients with bipolar disorder. He was the site principal investigator for the Systematic Treatment Enhancement Program for Bipolar Disorder and was involved in the Sequenced Treatment Alternatives to Relieve Depression study. His research interests focus on bipolar disorder, treatment-resistant depression, and the longitudinal course of affective disorders. Dr. Nierenberg has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994. This interview was conducted by Norman Sussman, MD, on December 8, 2006, and is published in the February 2007 Primary Psychiatry. Disclosure: Dr. Nierenberg is a consultant to BrainCells, Bristol-Myers Squibb, Eli Lilly, Genaissance, GlaxoSmithKline, Innapharma, Janssen, Novartis, Pfizer, Sepracor, Shire, and Somerset; receives grant support from Bristol-Myers Squibb, Cederroth, Cyberonics, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Lichtwer Pharma, the National Alliance for Research on Schizophrenia and Depression, the National Institute of Mental Health, Pfizer, the Stanley Foundation, and Wyeth; and receives honoraria from Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest, GlaxoSmithKline, and Wyeth. http://psychcast.mblcommunications.com/audio/04Nierenberg.m4a Thu, 22 Feb 2007 22:10:36 -0500 Medicine no 00:21:50 MBL Communications Treatment of Attention-Deficit/Hyperactivity Disorder Dr. Weisler is adjunct professor of psychiatry at the University of North Carolina School of Medicine at Chapel Hill and adjunct associate professor of psychiatry and behavioral sciences at Duke University Medical Center in Durham. Also a private practitioner in Raleigh, North Carolina, Dr. Weisler has been a principal investigator in more than 200 clinical studies and was named one of America’s top psychiatrists for 2002–2003 by the Consumers’ Research Council of America. Dr. Weisler is currently working on a project with the Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention to improve recognition and knowledge of disaster mental health for healthcare providers in the wake of Hurricanes Katrina and Rita. This interview was conducted by Norman Sussman, MD, on November 2, 2006, and is published in the January 2007 Primary Psychiatry. Disclosure: Dr. Weisler is a consultant to Agency of Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Bristol-Myers Squibb, Corcept, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, New River Pharmaceuticals, Novartis, Pfizer, sanofi-aventis, Shire, Solvay, and Wyeth; on the speaker’s bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Pfizer, sanofi-aventis, Shire, Solvay, and Wyeth; receives grant or research support from Abbott, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest, GlaxoSmithKline, Janssen, McNeil, MediciNova, Merck, the National Institute of Mental Health, Neurochem, New River Pharmaceuticals, Novartis, Pfizer, Saegis, sanofi-aventis, Shire, Solvay, Vela, and Wyeth; and owns stock in Bristol-Myers Squibb, Merck, and Pfizer. http://psychcast.mblcommunications.com/audio/03Weisler.m4a Tue, 16 Jan 2007 16:17:04 -0500 Medicine no 00:31:04 MBL Communications Treating Late-Life Depression Dr. Nelson is professor of psychiatry, director of geriatric psychiatry, and holds the Leon J. Epstein, MD, chair in geriatric psychiatry at the University of California, San Francisco. His research and expertise focus principally on the description and treatment of adult and geriatric depression, as well as the psychopharmacology of antidepressants. Among many accomplishments, Dr. Nelson received the Yale Residents Outstanding Teacher award in 1995 and 2001, and the Distinguished Yale Alumni Award in 2006. He wrote Geriatric Psychopharmacology in 1998. Dr. Nelson was one of the founding members of the American Society of Clinical Psychopharmacology and served as its president from 1999 to 2003. http://psychcast.mblcommunications.com/audio/02Nelson.m4a Wed, 13 Dec 2006 20:23:28 -0500 Medicine no 00:33:33 MBL Communications Treating Depression in Pregnancy http://psychcast.mblcommunications.com/audio/podcast1.m4a Tue, 14 Nov 2006 21:04:01 -0500 Medicine no 00:25:47